Hikma Pharmaceuticals rises on strong revenues and profits
Shares in Hikma Pharmaceuticals climbed by 8.38% to 1,785p (as of 12:30 BST) after group revenues rose by 11% during the first half of the year.
Shares in Hikma Pharmaceuticals climbed by 8.38% to 1,785p (as of 12:30 BST) after group revenues rose by 11% during the first half of the year.
FTSE 250 infrastructure firm Balfour Beatty has reported pre-tax profits of £50 million for the first half, a 150% improvement over H1 2017.
The Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence announced that they have formed Napa Therapeutics to develop drugs against an aging-related target.
FTSE 100 miner Antofagasta increased revenues by 3.6% to $2,120.7 million as higher realised prices outweighed lower volumes in copper markets.
Digital insurance outfit Esure has agreed an all cash recommended offer with a subsidiary of funds managed by Bain Capital.
AIM-listed Fusion Antibodies has warned that trading this year has been slower than expected, as competition has led to lower prices and delayed contracts.
Online contracts-f0r-difference specialist Plus500 increased its first half revenues by 147% as active customers more than doubled over the period.
Shipping services provider Clarkson saw revenues contract by 2.67% to £152.6 million during the six months ended 30th June.
Beverage giant Diageo has announced a £2 billion share buyback that will begin today and continue over the current financial year.
Clothing retailer Sports Direct International has purchased House of Fraser out of administration for a £90 million cash consideration.